Effects of Modified Low-Density Lipoproteins and Fenofibrate on an Outer Blood-Retina Barrier Model: Implications for Diabetic Retinopathy

Purpose: There is a lack of treatment for early diabetic retinopathy (DR), including blood-retina barrier (BRB) breakdown. The robust clinical benefit of fenofibrate in DR provides an opportunity to explore disease mechanisms and therapeutic targets. We have previously found that modified lipoprotei...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Dongxu, Yu, Jeremy Y., Connell, Anna R., Hookham, Michelle B., McLeese, Rebecca H., Lyons, Timothy J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757531/
https://www.ncbi.nlm.nih.gov/pubmed/33107777
http://dx.doi.org/10.1089/jop.2020.0068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757531/
https://www.ncbi.nlm.nih.gov/pubmed/33107777
http://dx.doi.org/10.1089/jop.2020.0068

Ejemplares similares